| dc.creator |
Afsar, Barış |
|
| dc.creator |
GÜNER, Ertugrul |
|
| dc.creator |
YILDIZ, Idris |
|
| dc.creator |
Elsurer, Rengin |
|
| dc.date |
2011-04-30T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T09:26:48Z |
|
| dc.date.available |
2020-10-06T09:26:48Z |
|
| dc.identifier |
13d49e65-645d-4183-a3d4-90e222fd00bb |
|
| dc.identifier |
10.1053/j.jrn.2010.04.006 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/13d49e65-645d-4183-a3d4-90e222fd00bb/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/53862 |
|
| dc.description |
Objectives: Patients with type 2 diabetes have lower intact parathyroid hormone (iPTH) levels when compared with non-diabetics. Patients with metabolic syndrome (MetSyn) have increased iPTH levels than normal subjects. We hypothesized that patients with type 2 diabetes and MetSyn might have higher iPTH levels as compared with those without MetSyn. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Targeting Parathyroid Hormone Level in Diabetic Patients With Stage 3 to 5 Chronic Kidney Disease: Does Metabolic Syndrome Matter? |
|
| dc.type |
info:eu-repo/semantics/article |
|